Ubs Asset Management Americas Inc Pulmonx Corp Transaction History

Ubs Asset Management Americas Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.88 - $14.0 $130,623 - $185,094	13,221 Added 89.05%	28,068 $289,000
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $111,204 - $186,181	14,847 New	14,847 $165,000
Q2 2022 Aug 12, 2022	SELL	$14.0 - $27.95 $124,418 - $248,391	-8,887 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $66,602 - $101,069	2,241 Added 33.72%	8,887 $285,000
Q3 2021 Nov 15, 2021	SELL	$35.98 - $44.48 $147,374 - $182,190	-4,096 Reduced 38.13%	6,646 $239,000
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $404,006 - $515,616	10,742 New	10,742 $473,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.